Rivaroxaban in clinical practice for atrial fibrillation with special reference to prothrombin time

Circulation Journal

Volumn 78, Issue 3, 2014, Pages 763-766

  Suzuki, Shinya ^a   Otsuka, Takayuki ^a   Sagara, Koichi ^a   Kano, Hiroto ^a   Matsuno, Shunsuke ^a   Kato, Yuko ^a   Takai, Hideaki ^a   Uejima, Tokuhisa ^a   Oikawa, Yuji ^a   Nagashima, Kazuyuki ^a   Kirigaya, Hajime ^a   Yajima, Junji ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a   Yamashita, Takeshi ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Anticoagulation; Atrial fibrillation; Rivaroxaban

Indexed keywords

RIVAROXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CREATININE CLEARANCE; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPIGASTRIC DISCOMFORT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; JAPANESE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROTHROMBIN TIME; VERY ELDERLY; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; BLOOD; CLINICAL TRIAL; JAPAN; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; FACTOR XA INHIBITORS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MORPHOLINES; PROSPECTIVE STUDIES; PROTHROMBIN TIME; THIOPHENES;

EID: 84894411342     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1380     Document Type: Article

References (5)

1. Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, et al. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation: The J-ROCKET AF study. Circ J 2012; 76: 2104-2111.
2. Samama M-M, Amiral J, Guinet C, Le Flem L, Seghatchian J. Monitoring plasma levels of factor Xa inhibitors: How, why and when? Expert Rev Hematol 2013; 6: 155-164.
3. Suzuki S, Yamashita T, Ohtsuka T, Sagara K, Uejima T, Oikawa Y, et al. Prevalence and prognosis of patients with atrial fibrillation in Japan: A prospective cohort of Shinken Database 2004. Circ J 2008; 72: 914-920.
4. Lip GYH, Lane DA. Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation: Focus on the elderly. Circ J 2013; 77: 1380-1388.
5. Samama MM, Martinoli J-L, LeFlem L, Guinet C, Plu-Bureau G, Depasse F, et al. Assessment of laboratory assays to measure rivaroxaban: An oral, direct factor Xa inhibitor. Thromb Haemost 2010; 103: 815-825.